Salarius Pharmaceuticals, Inc logo

Salarius Pharmaceuticals, Inc Investor Relations Material

Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focuses on developing epigenetic-based cancer treatments. Salarius Pharmaceuticals, Inc. is developing a new class of DNA-targeted anticancer agents that enable the suppression of tumor growth by reversing the aberrant epigenetic changes found in cancer cells. These DNA targeted agents are produced in a fully scalable process that allows rapid scale up to meet commercial demands and enable quick entry into clinical trials

Latest company events

Ticker symbol

SLRX

Country

United States of America

Dig deeper into the Salarius Pharmaceuticals, Inc fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot